(Q34664263)

3 August 2017

1 reference

title

Adherence to HAART among patients with HIV: breakthroughs and barriers (English)

1 reference

3 August 2017

0 references

2

Meade CS

1 reference

3 August 2017

Ickovics JR

1

1 reference

3 August 2017

publication date

1 June 2002

1 reference

3 August 2017

1 reference

3 August 2017

volume

14

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

309-318

1 reference

Trust and the acceptance of and adherence to antiretroviral therapy

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09540120220123685

Helping the urban poor stay with antiretroviral HIV drug therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120220123685

Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120220123685

Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120220123685

Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120220123685

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120220123685

Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120220123685

Factors affecting adherence to antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120220123685

Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AAC

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120220123685

Adherence to pharmacological interventions. Current trends and future directions. The Pharmacological Intervention Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120220123685

The relationship of disease severity, health beliefs and medication adherence among HIV patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120220123685

Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120220123685

Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120220123685

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120220123685

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120220123685

Doctor-patient interaction, patients' health behavior and effects of treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120220123685

Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120220123685

Adherence in AIDS clinical trials: a framework for clinical research and clinical care

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120220123685

Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120220123685

Adherence and effectiveness of highly active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120220123685

Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120220123685

Management of the adverse effects of antiretroviral therapy and medication adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120220123685

Enhancing adherence to combination antiretroviral therapy in non-adherent HIV-positive men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120220123685

A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120220123685

Determinants of subject compliance within an experimental anti-HIV drug protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120220123685

Measuring adherence to asthma medication regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120220123685

Cue-dose training with monetary reinforcement: pilot study of an antiretroviral adherence intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120220123685

Barriers to antiretroviral medication adherence in HIV-infected women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120220123685

Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: a cross-sectional study in a municipal hospital clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120220123685

Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120220123685

Adherence to antiretroviral therapy among HIV-infected methadone patients: effect of ongoing illicit drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120220123685

HIV/AIDS patients' perspectives on adhering to regimens containing protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120220123685

Prospective randomized two-Arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120220123685

Human immunodeficiency virus 1 protease inhibitors in clinical practice: predictors of virological outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120220123685

Adherence to zidovudine (AZT) among HIV-infected methadone patients: a pilot study of supervised therapy and dispensing compared to usual care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120220123685

10.1080/09540120220123685

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference